Chapter 14: List of principal anti-asthmatic agents

DOI Web Site 5 References

Bibliographic Information

Other Title
  • 第14章　主な抗喘息薬一覧表

Abstract

<p>The popularization of the Japanese Pediatric Guideline for the Treatment and Management of Bronchial Asthma (JPGL) has enabled standardization of the approach to pediatric bronchial asthma. This has resulted in the appropriate use of basic anti-asthmatic drugs for children. In chapter 14 of the JPGL 2020, the principal therapeutic agents for pediatric bronchial asthma are listed. These medications have remained almost unchanged over recent years except for updates on the information on biologics since JPGL 2017. In particular, the age of insurance coverage for use of mepolizumab has been lowered to at least 6 years and dupilumab has been newly approved for use in children over 12 years old. In addition, fluticasone propionate/formoterol fumarate hydrate has become available for children over 6 years of age. As with JPGL 2017, the table in chapter 14 was prepared based on the information obtained from the Pharmaceuticals and Medical Devices Agency. The contraindications and adverse reactions of these drugs are described separately. This article presents a brief discussion of the principal anti-asthmatic agents listed in chapter 14, by quoting the interpretations provided in the main text of JPGL 2020.</p>

Journal

References(5)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top